New drug IKS03 aims to shrink Hard-to-Treat lymphomas
NCT ID NCT05365659
First seen Nov 01, 2025 · Last updated Apr 29, 2026 · Updated 27 times
Summary
This early-phase trial tests a new drug called IKS03 in about 140 adults with advanced B-cell non-Hodgkin lymphoma that has not responded to other treatments. IKS03 is designed to seek out and attack cancer cells while sparing healthy ones. The main goals are to find the safest dose and see if the drug can shrink tumors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B-CELL LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Clinico Universitario de Salamanca
RECRUITINGSalamanca, Spain
Contact
Contact
-
Hospital Universitario Quironsalud Madrid
RECRUITINGMadrid, Spain
Contact
Contact
-
Institut Catala D'Oncologia
RECRUITINGBadalona, Spain
Contact
Contact
-
Istituto Europeo Clinico Humanitas
RECRUITINGMilan, Italy
Contact
Contact
-
Istituto Europeo di Oncologia
RECRUITINGMilan, Italy
Contact
Contact
-
Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale San Raffaele
RECRUITINGMilan, Italy
Contact
Contact
-
Jewish General Hospital
RECRUITINGMontreal, Quebec, H3T 1E2, Canada
Contact
Contact
-
La Fondazione e l'Istituto di Candiolo
RECRUITINGCandiolo, Italy
Contact
Contact
-
Linear Clinical Research
RECRUITINGPerth, Western Australia, Australia
Contact
Contact
-
Royal Adelaide Hospital
RECRUITINGAdelaide, South Australia, Australia
Contact
Contact
-
Royal Hobart Hospital
RECRUITINGHobart, Tasmania, 7000, Australia
Contact
-
University of Maryland Baltimore
WITHDRAWNBaltimore, Maryland, 21201, United States
-
Westmead Hospital
RECRUITINGWestmead, New South Wales, 2145, Australia
Contact
Conditions
Explore the condition pages connected to this study.